Skip to content
Search

Latest Stories

GPhC seeks views on draft standards for chief pharmacists

Patients, carers, and members of the public are encouraged to share what they think about the new draft standards

The General Pharmaceutical Council (GPhC) has developed new draft Standards for Chief Pharmacists to strengthen pharmacy governance.


It has set out the professional responsibilities as well as described the knowledge, conduct, and performance required by a chief pharmacist (or equivalent) to support their organisation and its staff to deliver "safe and effective" pharmacy services.

The pharmacy regulator has also launched a consultation to find out what patients, carers, and members of the public think about the new draft standards.

Participants can share their views “if there are any settings in which the standards could not be applied or met and any positive or negative impacts of the proposals," it said.

The survey will open for 12 weeks, from 23 January to 16 April 2024.

GPhC Chief Executive Duncan Rudkin commented: “Our draft Standards for chief pharmacists will complement our existing standards for all pharmacy professionals, strengthening assurance around these critical roles and empowering pharmacy professionals at a time of great challenge and opportunity for the professions.

“We are committed to listening carefully to all views expressed to make sure that the standards reflect the views and needs of patients and the public, health professionals, the NHS and the wider health sector.”

These draft standards were developed following new legislation which “removes the threat of criminal penalties for accidental or unintentional preparation and dispensing errors by pharmacy staff working in hospitals and similar settings,” the council clarified.

It emphasised that protection from prosecution helps to promote an "open and learning culture" which is vital for patient safety.

These rules already apply to pharmacy staff working in registered pharmacies (community pharmacies).

Further, it elaborated that to benefit from the new rules, a hospital (or relevant setting) must have a Chief Pharmacist (or equivalent) in post, who must be a registered pharmacist with the appropriate skills, training, and experience; and they must meet the Standards for Chief Pharmacists.

This is part of a wider programme, which aims to provide clarity around how pharmacies are organised and managed to ensure that patients and the public continue to receive safe and effective pharmacy care, the council added.

In the future, the regulator plans to develop and organise consultations on rules and professional standards for responsible pharmacists, and professional standards for superintendent pharmacists.

 

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less